Literature DB >> 23066448

Evolution of a Compact Photoprobe for the Dopamine Transporter Based on (±)-threo-Methylphenidate.

David J Lapinsky1, Nageswari Yarravarapu, Tammy L Nolan, Christopher K Surratt, John R Lever, Michael Tomlinson, Roxanne A Vaughan, Howard M Deutsch.   

Abstract

The development of photoaffinity ligands for determining covalent points of attachment to the dopamine transporter (DAT) has predominantly focused on tropane-based compounds bearing variable-length linkers between the photoreactive group and inhibitor pharmacophore. In order to expand the array of photoprobes useful for mapping inhibitor-binding pockets within the DAT, a compact non-tropane ligand was synthesized featuring a photoreactive azide and iodine tag directly attached to the aromatic ring of (±)-threo-methylphenidate. (±)-threo-4-Azido-3-iodomethylphenidate ((±)-6); K(i) = 4.0 ± 0.8 nM) displayed high affinity for hDAT. Moreover, a radioiodinated analog of (±)-6 demonstrated covalent ligation to the DAT in cultured cells and rat striatal membranes, thus suggesting the potential utility of this photoprobe in DAT structure-function studies.

Entities:  

Year:  2012        PMID: 23066448      PMCID: PMC3469269          DOI: 10.1021/ml3000098

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  26 in total

1.  Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.

Authors:  Mark Froimowitz; Yonghong Gu; Les A Dakin; Pamela M Nagafuji; Charles J Kelley; Damon Parrish; Jeffrey R Deschamps; Aaron Janowsky
Journal:  J Med Chem       Date:  2007-01-25       Impact factor: 7.446

2.  Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis.

Authors:  R A Vaughan; M J Kuhar
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

3.  Asymmetric synthesis and pharmacology of methylphenidate and its para-substituted derivatives.

Authors:  D L Thai; M T Sapko; C T Reiter; D E Bierer; J M Perel
Journal:  J Med Chem       Date:  1998-02-12       Impact factor: 7.446

4.  Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling.

Authors:  David J Lapinsky; Ranganadh Velagaleti; Nageswari Yarravarapu; Yi Liu; Yurong Huang; Christopher K Surratt; John R Lever; James D Foster; Rejwi Acharya; Roxanne A Vaughan; Howard M Deutsch
Journal:  Bioorg Med Chem       Date:  2010-11-04       Impact factor: 3.641

5.  Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.

Authors:  Okechukwu T Ukairo; Corry D Bondi; Amy Hauck Newman; Santosh S Kulkarni; Alan P Kozikowski; Stephen Pan; Christopher K Surratt
Journal:  J Pharmacol Exp Ther       Date:  2005-05-05       Impact factor: 4.030

6.  (-)-3 beta-Substituted ecgonine methyl esters as inhibitors for cocaine binding and dopamine uptake.

Authors:  S F Lieske; B Yang; M E Eldefrawi; A D MacKerell; J Wright
Journal:  J Med Chem       Date:  1998-03-12       Impact factor: 7.446

7.  Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties.

Authors:  Kyle C Schmitt; Juan Zhen; Prashant Kharkar; Manoj Mishra; Nianhang Chen; Aloke K Dutta; Maarten E A Reith
Journal:  J Neurochem       Date:  2008-09-11       Impact factor: 5.372

8.  Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.

Authors:  Deog-Il Kim; Howard M Deutsch; Xiaocong Ye; Margaret M Schweri
Journal:  J Med Chem       Date:  2007-05-10       Impact factor: 7.446

9.  Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.

Authors:  Claus J Loland; Rajeev I Desai; Mu-Fa Zou; Jianjing Cao; Peter Grundt; Klaus Gerstbrein; Harald H Sitte; Amy Hauck Newman; Jonathan L Katz; Ulrik Gether
Journal:  Mol Pharmacol       Date:  2007-10-31       Impact factor: 4.436

10.  Differential binding of tropane-based photoaffinity ligands on the dopamine transporter.

Authors:  R A Vaughan; G E Agoston; J R Lever; A H Newman
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

View more
  1 in total

1.  Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram.

Authors:  Vivek Kumar; Nageswari Yarravarapu; David J Lapinsky; Danielle Perley; Bruce Felts; Michael J Tomlinson; Roxanne A Vaughan; L Keith Henry; John R Lever; Amy Hauck Newman
Journal:  J Med Chem       Date:  2015-07-08       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.